Caribou Biosciences, Inc. (CRBU)
0.4994
+0.04
(+8.52%)
USD |
NASDAQ |
Oct 12, 16:00
0.4994
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Price : 0.4994 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 0.46 | 0.5194 | 0.4425 | 0.4602 | 9.738M |
| Oct 08, 2026 | 0.5938 | 0.5968 | 0.4503 | 0.4812 | 19.34M |
| Oct 07, 2026 | 0.636 | 0.67 | 0.546 | 0.6174 | 37.51M |
| Oct 06, 2026 | 1.19 | 1.215 | 1.13 | 1.135 | 5.939M |
| Oct 05, 2026 | 1.22 | 1.24 | 1.17 | 1.19 | 1.547M |
| Oct 02, 2026 | 1.24 | 1.24 | 1.215 | 1.22 | 866573.0 |
| Oct 01, 2026 | 1.27 | 1.285 | 1.22 | 1.22 | 687396.0 |
| Sep 30, 2026 | 1.278 | 1.285 | 1.25 | 1.27 | 845067.0 |
| Sep 29, 2026 | 1.25 | 1.265 | 1.22 | 1.24 | 637085.0 |
| Sep 28, 2026 | 1.25 | 1.26 | 1.22 | 1.23 | 818633.0 |
| Sep 25, 2026 | 1.25 | 1.27 | 1.22 | 1.24 | 901268.0 |
| Sep 24, 2026 | 1.29 | 1.29 | 1.25 | 1.25 | 978905.0 |
| Sep 23, 2026 | 1.34 | 1.36 | 1.29 | 1.29 | 700029.0 |
| Sep 22, 2026 | 1.32 | 1.36 | 1.31 | 1.34 | 1.217M |
| Sep 21, 2026 | 1.31 | 1.35 | 1.29 | 1.30 | 753310.0 |
| Sep 18, 2026 | 1.33 | 1.34 | 1.30 | 1.30 | 1.854M |
| Sep 17, 2026 | 1.27 | 1.330 | 1.26 | 1.31 | 1.257M |
| Sep 16, 2026 | 1.28 | 1.29 | 1.25 | 1.25 | 969353.0 |
| Sep 15, 2026 | 1.31 | 1.31 | 1.25 | 1.27 | 1.692M |
| Sep 14, 2026 | 1.275 | 1.33 | 1.25 | 1.29 | 1.686M |
| Sep 11, 2026 | 1.38 | 1.40 | 1.26 | 1.27 | 2.434M |
| Sep 10, 2026 | 1.43 | 1.44 | 1.35 | 1.37 | 1.261M |
| Sep 09, 2026 | 1.54 | 1.54 | 1.44 | 1.44 | 1.768M |
| Sep 08, 2026 | 1.57 | 1.58 | 1.54 | 1.54 | 717627.0 |
| Sep 04, 2026 | 1.57 | 1.60 | 1.55 | 1.57 | 1.329M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 12.66 |
| Vir Biotechnology, Inc. | 11.32 |
| Arrowhead Pharmaceuticals, Inc. | 60.80 |
| Oncolytics Biotech, Inc. | 0.4717 |
| Sangamo Therapeutics, Inc. | 0.1478 |
Price Related Metrics
| PS Ratio | 4.786 |
| Price to Book Value | 0.5396 |
| Earnings Yield | -215.8% |
| Market Cap | 52.93M |